Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remegal in partial seizures
NCT01749046Phase 3Completed
- Sponsor
- Valexfarm
- Start
- Mar 2012
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Remegal in focal seizures, sponsored by Valexfarm. Started Mar 2012; status: completed.
02
Drugs
Remegal
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT01749046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749046.